FDA Approves First AI-Powered Skin Cancer Diagnostic Tool
…clinical study. January 17, 2024 – original article in Targeted Oncology Sabrina Serani DermaSensor provides quantitative, point-of-testing identification for…
FDA Approves First AI-Powered Skin Cancer Diagnostic Tool
…clinical study. January 17, 2024 – original article in Targeted Oncology Sabrina Serani DermaSensor provides quantitative, point-of-testing identification for…
,
,
Secure Your Legacy With a Click
Ways to Give: Estate Gifts First Article in a Series Here at AIM at Melanoma, we are fortunate to be…
,
April 2025 Newsletter
This month, we delve into one of the most groundbreaking developments in melanoma research: vaccines. Our spotlight article examines the potential of mRNA…
AYA Cancer Conversation: Navigating Young Adult Cancer
We’re excited to share the latest episode of the AIM at Melanoma podcast, featuring an inspiring conversation with Abby Singh,…
,
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
…NSCLC. Improved Survival in Patients with Metastatic Melanoma Patients with metastatic melanoma who received a COVID-19 mRNA vaccine within 100…
,
Young Adult Cancer & Mental Health
In this episode of Beyond the Clinic: Living Well with Melanoma, host Dr. Samantha Siegel sits down with Dr. Victoria…
,
Advocates Renew Call for RP1 Approval
As the U.S. Food and Drug Administration approaches a pivotal decision on a potential new treatment for advanced melanoma, patient…
,
Grocery Shopping Tips for Melanoma Caregivers
…to keep the food at a safe temperature until you make it home. Check the dates: Melanoma patients often have decreased…
,
Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
,
Navigating Melanoma During the Holidays
The holiday season is often portrayed as a time of joy, love, and celebration. However, for melanoma cancer patients, it…
,
Recent Posts
Aug. 31, 2026
Women in Melanoma: A New Chapter in Europe
Aug. 31, 2026
The Legal & Financial Side of a Diagnosis: What No One Tells You
Aug. 19, 2026
Positive Phase 3 Results for Personalized mRNA Therapy in Melanoma
Aug. 07, 2026
RP1 Approved: A Long Road to a New Option for Patients
Aug. 06, 2026